Trending Stocks : AT&T (NYSE:T), Sprint Corporation (NYSE:S), Avanir Pharmaceuticals (NASDAQ:AVNR), Booz Allen Hamilton (NYSE:BAH), Syngenta (NYSE:SYT)

Zacks reissued their outperform rating on shares of AT&T (NYSE:T) in a research report released on Wednesday morning. Zacks currently has a $12.00 price objective on the stock. AT&T, Inc. (NYSE:T)’s stock on 31 July traded at beginning with a price of $36.05 and when day-trade ended the stock finally fell -2.12% to end at $35.59. AT&T, Inc. (NYSE:T)’s showed weekly performance of 0.25%.

Sprint Corporation (NYSE:S) fell as French telecommunications company Iliad announced a bid to buy T-Mobile (TMUS_).  Iliad has offered $15 billion in cash for 56.6% of T-Mobile, or $33 a share, according to The Wall Street Journal. Sprint and T-Mobile had agreed on broad strokes of a merger that would value T-Mobile at $30 billion and would combine the third-largest and fourth-largest U.S. wireless carriers, respectively.  Sprint Corporation (NYSE:S) on Thursday closed at $7.35. Stock institutional ownership is 18.20% while insider ownership includes 0.30%. Sprint Corporation (NYSE:S) distance from 50-day simple moving average (SMA50) is -13.98%.

On July 28, 2014, Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) will report financial results for the quarter ended June 30, 2014 after market close on Tuesday, August 5, 2014. The company will conduct a conference call and an audio webcast at 1:30 pm Pacific Time (4:30 pm Eastern Time) on the same day.  Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR)’s shares on Thursday traded in the range of 5.21 – 5.44and ended up on $5.21. Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) distance from 200-day simple moving average (SMA200) is 21.01%. AVNR’s sales growth for past 5 years was 60.90% and its EPS growth for past 5 years was -14.40%.

Investment analysts at JPMorgan Chase & Co. hoisted their target price on shares of Booz Allen Hamilton Holding Corp. (NYSE:BAH) from $25.00 to $26.00 in a note issued to investors on Thursday. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.’s price target suggests a potential upside of 15.66% from the stock’s previous close. Booz Allen Hamilton Holding Corporation (NYSE:BAH)’s stock on 31 July fell -1.07% to the closing price of $22.24. Its fifty two weeks range is $16.61 – 25.32. The total market capitalization recorded $3.222B. Booz Allen Hamilton Holding Corporation (NYSE:BAH) monthly performance is 3.11%.

Syngenta AG (NYSE:SYT) recently reported financial results for the first half of 2014 (ended Jun 30, 2014). Earnings per share, excluding restructuring and impairment charges, came in at $15.60 (or $3.12 per ADR), down 2.0% from $15.92 reported in the first half of 2013. In the reported half year, sales climbed 1% year over year to $8,508 million year over year. At Constant Exchange Rate (:CER), revenues increased 4% backed by price and volume gains. Syngenta AG (NYSE:SYT) on Thursday closed at $70.94. Stock institutional ownership is 4.10%. Syngenta AG (NYSE:SYT) distance from 50-day simple moving average (SMA50) is -5.41%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone